Rekik M, Abid M, Hachicha J, Abbes R, Moujahed M, Jarraya A
Service de Médecine interne, CHU Hèdi Chaker, Sfax, Tunisie.
Bull World Health Organ. 1994;72(4):611-4.
The direct costs were determined by conducting a retrospective study on the files of 100 diabetics (selected at random) who had attended the clinic at least once in 1991. Another study was conducted simultaneously under the same conditions on 100 non-diabetic patients. Diabetic patients attend on average 8 times a year, twice as often as nondiabetics, generally at the department of general medicine (6 times). They undergo more biological tests and receive more care procedures than nondiabetics. Drug prescriptions cost on average US$ 62 per year for the diabetic, 3 times as much as for the non-diabetic (US$ 20/year). The total direct cost of outpatient care is US$ 117 per year for the diabetic, as against only US$ 48 for the nondiabetic. The cost is much higher for diabetics with degenerative complications (US$ 144 as against US$ 92). Reduction of the cost of care requires early detection of diabetes and education of the diabetic, so as to ensure better control of blood sugar levels and freedom from complications that lead to a sharp increase in consultations and treatment procedures.
通过对1991年至少就诊过一次该诊所的100名糖尿病患者(随机选取)病历进行回顾性研究来确定直接成本。同时在相同条件下对100名非糖尿病患者进行了另一项研究。糖尿病患者平均每年就诊8次,就诊频率是非糖尿病患者的两倍,通常在内科就诊(6次)。他们比非糖尿病患者接受更多的生物检测和护理程序。糖尿病患者每年的药物处方平均费用为62美元,是非糖尿病患者的3倍(每年20美元)。糖尿病患者门诊护理的总直接成本为每年117美元,而非糖尿病患者仅为48美元。患有退行性并发症的糖尿病患者成本要高得多(分别为144美元和92美元)。降低护理成本需要早期发现糖尿病并对糖尿病患者进行教育,以确保更好地控制血糖水平并避免出现导致就诊和治疗程序急剧增加的并发症。